Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Rheumatology|June 18, 2004
Psoriasis vulgaris: an interplay of T lymphocytes, dendritic cells, and inflammatory cytokines in pathogenesisFrancesca Chamian, James G Krueger
International Journal of Cancer|March 18, 2004
Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansionKavita M Dhodapkar, Barbara Cirignano, Francesca Chamian, et al.
BMC Dermatology|February 28, 2007
Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case seriesMichelle A Lowes, Francesca Chamian, Maria V Abello, et al.
The Journal of Experimental Medicine|January 7, 2004
Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgarisEdmund Lee, William L Trepicchio, Judith L Oestreicher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaquesAlice B Gottlieb, Francesca Chamian, Salman Masud, et al.
The Journal of Investigative Dermatology|April 29, 2006
Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: Gene regulation and cellular effectsFrank Wang, Edmund Lee, Michelle A Lowes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patientsAsifa S Haider, Michelle A Lowes, Humphrey Gardner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2005
Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgarisFrancesca Chamian, Michelle A Lowes, Shao-Lee Lin, et al.
Pageof 2